NEOS Investment Management’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.62M Buy
12,915
+1,621
+14% +$426K 0.01% 426
2026
Q1
$3.01M Buy
11,294
+8,544
+311% +$2.31M 0.02% 421
2025
Q4
$690K Buy
2,750
+11
+0.4% +$2.92K ﹤0.01% 581
2025
Q3
$786K Buy
2,739
+1,766
+182% +$473K 0.01% 544
2025
Q2
$255K Buy
973
+6
+0.6% +$1.46K ﹤0.01% 594
2025
Q1
$225K Buy
967
+1
+0.1% +$243 ﹤0.01% 579
2024
Q4
$222K Sell
966
-7
-0.7% -$1.61K 0.01% 576
2024
Q3
$217K Buy
+973
New +$214K 0.01% 565
2024
Q2
Sell
-973
Closed -$213K 575
2024
Q1
$213K Sell
973
-21
-2% -$4.63K 0.01% 546
2023
Q4
$226K Buy
+994
New +$209K 0.02% 470

Other funds holding LH

NEOS Investment Management's LH Position: Q2 2026 in Review

NEOS Investment Management increased its Labcorp (LH) stake by 14% in Q2 2026, buying an estimated $426K and bringing the position to 12,915 shares worth $3.62M. The position accounts for 0.01% of the portfolio, ranked #426.

NEOS Investment Management first reported a position in LH in Q4 2023 and has held it in 10 quarters since. 1,051 funds tracked by Wall St. Rank hold LH as of Q2 2026.

  • NEOS Investment Management held 12,915 shares of Labcorp worth $3.62M as of Q2 2026.
  • NEOS Investment Management bought 1,621 Labcorp shares in Q2 2026, an estimated $426K.
  • Labcorp made up 0.01% of NEOS Investment Management's portfolio in Q2 2026, its #426 holding.
  • NEOS Investment Management first reported a position in Labcorp in Q4 2023 and has held it in 10 quarters since.
  • 1,051 funds tracked by Wall St. Rank held Labcorp as of Q2 2026.

Based on NEOS Investment Management's 13F filing for Q2 2026, filed 11 Aug 2026.